Follow on Google News Industry News News By Location Country(s) Industry News
Follow on Google News | AnaSpec Introduces Novel Solid Support AMC ResinAnaSpec has announced the development of a novel solid support AMC resin for facile solid-phase synthesis of peptide-AMCs.
By: Albert O. Hong Peptide-7-amino- AnaSpec, Eurogentec’s newest North American division, has announced the development of a novel solid support AMC resin for facile solid-phase synthesis of peptide-AMCs. As shown in Figure 1, N-Fmoc-7-aminocoumarin- AMC resins preloaded with Asp (D) and Arg (R) for use in SPPS, as well as Fmoc-ACA-OH are now only available from AnaSpec. About AnaSpec AnaSpec is a leading provider of integrated proteomics solutions to the world’s largest biotech, pharmaceutical, and academic research institutions. With a vision for innovation through synergy, AnaSpec focuses on three core technologies: AnaSpec recently joined forces with Eurogentec to provide an even broader spectrum of products and services to serve the worldwide life science community. For more information visit www.anaspec.com About Eurogentec Eurogentec is a leading global supplier of innovative reagents, kits, specialty products and custom services to scientists in the life science, biotechnology, pharmaceutical and diagnostic markets. Eurogentec provides a wide range of expertize in small- and large-scale DNA, RNA, PCR and qPCR kits, peptide synthesis and antibody supply for research applications. Our ISO13485:2003- Eurogentec is a privately held company headquartered in Liège, Belgium, with subsidiaries in North America, France, Germany, the UK, the Netherlands and Switzerland and has additional production facilities in North America, Japan and Singapore. Eurogentec employs 400+ people globally. For more information visit www.eurogentec.com # # # AnaSpec, Inc. is a leading provider of integrated proteomics solutions™ for worldwide life science research. AnaSpec offers expertise in three primary technologies: End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|